GHRS
Price
$10.09
Change
+$0.23 (+2.33%)
Updated
Apr 4 closing price
Capitalization
625.86M
39 days until earnings call
IBRX
Price
$2.83
Change
-$0.14 (-4.71%)
Updated
Apr 4 closing price
Capitalization
2.42B
33 days until earnings call
Ad is loading...

GHRS vs IBRX

Header iconGHRS vs IBRX Comparison
Open Charts GHRS vs IBRXBanner chart's image
GH Research
Price$10.09
Change+$0.23 (+2.33%)
Volume$261.8K
Capitalization625.86M
ImmunityBio
Price$2.83
Change-$0.14 (-4.71%)
Volume$7.97M
Capitalization2.42B
GHRS vs IBRX Comparison Chart
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. IBRX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Hold and IBRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (GHRS: $9.86 vs. IBRX: $2.97)
Brand notoriety: GHRS and IBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 33% vs. IBRX: 101%
Market capitalization -- GHRS: $625.86M vs. IBRX: $2.42B
GHRS [@Biotechnology] is valued at $625.86M. IBRX’s [@Biotechnology] market capitalization is $2.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 0 FA rating(s) are green whileIBRX’s FA Score has 1 green FA rating(s).

  • GHRS’s FA Score: 0 green, 5 red.
  • IBRX’s FA Score: 1 green, 4 red.
According to our system of comparison, GHRS is a better buy in the long-term than IBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 4 TA indicator(s) are bullish while IBRX’s TA Score has 4 bullish TA indicator(s).

  • GHRS’s TA Score: 4 bullish, 6 bearish.
  • IBRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than GHRS.

Price Growth

GHRS (@Biotechnology) experienced а -19.51% price change this week, while IBRX (@Biotechnology) price change was -11.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

GHRS is expected to report earnings on May 14, 2025.

IBRX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.42B) has a higher market cap than GHRS($626M). GHRS YTD gains are higher at: 40.857 vs. IBRX (16.016). GHRS has higher annual earnings (EBITDA): -38.6M vs. IBRX (-264.43M). IBRX (150M) and GHRS (149M) have equal amount of cash in the bank . GHRS has less debt than IBRX: GHRS (624K) vs IBRX (504M). IBRX has higher revenues than GHRS: IBRX (14.7M) vs GHRS (0).
GHRSIBRXGHRS / IBRX
Capitalization626M2.42B26%
EBITDA-38.6M-264.43M15%
Gain YTD40.85716.016255%
P/E RatioN/AN/A-
Revenue014.7M-
Total Cash149M150M99%
Total Debt624K504M0%
FUNDAMENTALS RATINGS
IBRX: Fundamental Ratings
IBRX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRSIBRX
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
90%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCLGX12.17N/A
N/A
Optimum Large Cap Growth C
JVASX38.25N/A
N/A
JPMorgan Value Advantage I
LLSCX28.09N/A
N/A
Longleaf Partners Small-Cap
CSSAX25.80N/A
N/A
Carillon Chartwell Small Cap A
LCFLX13.09N/A
N/A
Lord Abbett Focused Large Cap Value C